Trial Profile
European phase II trial of TAK 875 in patients with type 2 diabetes mellitus.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2011
Price :
$35
*
At a glance
- Drugs Fasiglifam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 04 Jul 2011 New trial record